About us

Ai Mediq is a Luxembourg-based ground-breaking medical technology company that develops novel non-invasive therapeutic solutions leveraging positive treatment effects of high altitude (hypoxic) exposure, medical devices for Intermittent Hypoxic Treatment, and medical software algorithms for its personalisation.

Ai Mediq is the first company in the world which commercialised the idea of using physiological effects of adaptation to short term episodes of hypoxia for clinical treatment purposes.

In 2014, the company has developed a medical device called ReOxy® for provision of an innovative breathing therapy method: Intermittent Hypoxic Hyperoxic Treatments (IHHT) with a biological feedback SRT® (Self-Regulated Treatment) technology.
Following successful commercialisation of the initial ReOxy version, Ai Mediq is now focused on adaptation and optimisation of the ReOxy device to novel markets with significant potential benefits for patients, customers and healthcare systems alike.

Company R&D Activities as a Private Sector Research Organization
Since 2013 Ai Mediq has focused its efforts on:

  1. Research for the objectives:
    • to scientifically evaluate influence of short-term, individually dosed, physiological feedback-controlled hypoxic exposure in healthy subjects and patients with different diseases (basic research)
    • to evaluate efficacy of IHHT in rehabilitation of patients with cardiovascular, cerebrovascular and metabolic disorders</li.
  2. Feasibility studies for the objectives:
    • to validate efficacy and performance level of the IHHT/ SRT method intended for in- and outpatient markets over conventional supervised exercise-based cardiac rehabilitation methods.
  3. Development of new innovative medical devices/their Prototyping (Industrial Research/Industrial Development)
Quality and safety

Ai Mediq provides a timely and effective control over every stage of production.

All our suppliers are certified in the EN ISO 13485 and ISO 9000:2000 standards.

We continuously monitor our suppliers to secure the highest achievable quality of the final product.

Every product and service Ai Mediq offers is compliant with the EN ISO 13485 International Standard and MDD regulations MDD (93/42 EEC); EN 60601-1 (safety) / EN 60601-1-2 (EMC) criteria.

Our products are highly effective and always safe.

ReOxy breathing therapy device is a device that was developed based on latest developments in medical devices and electronics.

ReOxy is manufactured by Bitmos GmbH and is CE marked and produced in full compliance to 93/42/EEC (Medical Devices Directive – MDD), facilitating high quality and safety of operation.

Every Ai Mediq employee and subcontractor is proud of the excellent quality of its products.

This helps us to meet and exceed our customers expectations.